We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 906 results
  1. Neurobehavioral Outcomes of Children with Antenatal Exposure to Antiseizure Medications

    Objectives

    To evaluate the effect of antiepileptic medications prescribed to mothers during pregnancy on the development and behavior of children.

    ...
    Deepa Bhaskaran, Sanjeev Thomas, Liss Maria Scaria in Indian Journal of Pediatrics
    Article 08 June 2024
  2. Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis

    Background and Objective

    Drug–drug interactions between direct oral anticoagulants (DOAC) and antiseizure medications via the cytochrome P450 (CYP) or...

    Bonaventure Y. Ip, Ho Ko, ... Thomas W. Leung in CNS Drugs
    Article Open access 24 November 2022
  3. Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment

    The use of direct oral anticoagulants (DOACs) is increasing because of their superior efficacy and safety compared with vitamin K antagonists....

    Rachel Goldstein, Aviya R. Jacobs, ... Mordechai Muszkat in CNS Drugs
    Article 03 March 2023
  4. Sex Differences in Adverse Effects of Antiseizure Medications in Adults with Epilepsy: A Systematic Review

    Background

    Sex differences in epilepsy have been described in prevalence, seizure propensity and response to treatment. Therefore, taking into account...

    Loretta Giuliano, Vania Durante, ... Barbara Mostacci in CNS Drugs
    Article 30 April 2024
  5. Newer Antiseizure Medications and Suicidality: Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) Database

    Background

    The association between antiseizure medications (ASMs) and suicidality remains controversial. Analyses of additional datasets are needed to...

    Emily E. Leppien, Bennett J. Doughty, ... Kenneth L. McCall in Clinical Drug Investigation
    Article 15 May 2023
  6. Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis

    Objectives

    To compare the efficacy and safety of antiseizure medications (ASMs), both as monotherapies and adjunctive therapies, for idiopathic...

    Hongyuan Chu, **nyu Zhang, ... Xu Yang in Journal of Neurology
    Article Open access 28 June 2023
  7. The Effect of Levetiracetam Compared with Enzyme-Inducing Antiseizure Medications on Apixaban and Rivaroxaban Peak Plasma Concentrations

    Background and Objective

    Post-stroke epilepsy represents an important clinical challenge as it often requires both treatment with direct oral...

    Rachel Goldstein, Natalie Rabkin, ... Mordechai Muszkat in CNS Drugs
    Article Open access 23 March 2024
  8. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis

    Background

    Overall, up to one-third of epilepsy patients have drug-resistant epilepsy. However, there was previously no meta-analysis to support the...

    Hecheng Wang, Haoran Wang, ... Yanshuo Han in CNS Drugs
    Article 17 August 2023
  9. Pilot study on the probability of drug-drug interactions among direct oral anticoagulants (DOACs) and antiseizure medications (ASMs): a clinical perspective

    Abstract Background

    There is little and controversial information about changes in plasma concentrations (PCs) or clinical events during...

    Federica Ranzato, Roberta Roberti, ... Gianfranco Di Gennaro in Neurological Sciences
    Article Open access 07 August 2023
  10. Impact of Antiseizure Medications on Appetite and Weight in Children

    There are numerous potential factors that may affect growth in children with epilepsy, and these must be evaluated in any child with appetite and...

    Ersida Buraniqi, Hicham Dabaja, Elaine C. Wirrell in Pediatric Drugs
    Article 21 May 2022
  11. Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials

    Introduction

    This article aimed to assess the efficacy and tolerability of adjunctive brivaracetam (BRV) in adults with focal-onset seizures on...

    Brian Moseley, Dimitrios Bourikas, ... Simon Borghs in Advances in Therapy
    Article Open access 15 February 2024
  12. A pilot study on identifying gene signatures as markers for predicting patient response to antiseizure medications

    The majority of the biomarkers were associated with the diagnosis of epilepsy and few of them can be applied to predict the response to antiseizure...

    Yifei Duan, Liyuan Kang, ... Lei Chen in Neurological Sciences
    Article 20 January 2023
  13. A Review of the Selected and Newer Antiseizure Medications Used in Childhood Epilepsies

    There have been additions of newer antiseizure medications in the armamentarium of clinicians for the management of epilepsy. The newer antiseizure...

    Samata Singhi, Ajay Gupta in Indian Journal of Pediatrics
    Article 10 August 2021
  14. Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy

    Background

    Antiseizure medication (ASM) as monotherapy or in combination is the treatment of choice for most patients with epilepsy. Therefore,...

    Laurent M. Willems, Milena van der Goten, ... Adam Strzelczyk in CNS Drugs
    Article Open access 04 June 2023
  15. Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations

    Introduction

    Our objective was to provide expert consensus recommendations to improve treatment tolerability through dose adjustments of concomitant...

    Michael C. Smith, Pavel Klein, ... William E. Rosenfeld in Neurology and Therapy
    Article Open access 03 September 2022
  16. Incidence of Acute Renal Failure in Patients Using Levetiracetam Versus Other Antiseizure Medications: A Voluntary Post-Authorization Safety Study

    Introduction

    Acute kidney injury is an expected adverse drug reaction listed in the European Union (EU) Summary of Product Characteristics (SmPC) for...

    Raphaelle Beau-Lejdstrom, Lai San Hong, ... Nadia Foskett in Drug Safety
    Article 28 June 2022
  17. Pregnancy, folic acid, and antiseizure medication

    Background

    Although some antiseizure medications (ASMs) are teratogenic, most people with epilepsy need treatment in pregnancy. The risk of ASM...

    Marte-Helene Bjørk, Håkon Vegrim, ... Elisabeth Synnøve Nilsen Husebye in Clinical Epileptology
    Article Open access 03 July 2023
  18. Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy

    Ritonavir-boosted nirmatrelvir (RBN) has been authorized recently in several countries as an orally active anti-SARS-CoV-2 treatment for patients at...

    Maor Wanounou, Yoseph Caraco, ... Emilio Perucca in Clinical Pharmacokinetics
    Article 27 July 2022
  19. Psychiatric implications of anti-seizure medications in epileptic population

    Background and objective

    Epilepsy is a prevalent neurological disorder that affects a significant number of individuals globally. This condition is...

    Bushra Khalid, Zaid Waqar, ... Zeeshan Munawar in BMC Neurology
    Article Open access 21 May 2024
Did you find what you were looking for? Share feedback.